Hillsdale Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Hillsdale Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,000	Closed	-$431K	–	638
2022 Q2	$431K	Buy	6,000 +100	+2%	+$7.31K	0.03%	373
2022 Q1	$477K	Hold	5,900	–	–	0.03%	376
2021 Q4	$606K	Sell	5,900 -900	-13%	-$86.4K	0.04%	359
2021 Q3	$595K	Hold	6,800	–	–	0.05%	361
2021 Q2	$608K	Buy	+6,800	New	+$575K	0.05%	337

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hillsdale Investment Management's SYNH Position: Q3 2022 in Review

Hillsdale Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 6,000 shares — an estimated $431K sold.

Hillsdale Investment Management first reported a position in SYNH in Q2 2021 and held it in 5 quarters. The position peaked at $608K in Q2 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Hillsdale Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Hillsdale Investment Management sold 6,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $431K.
Hillsdale Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 5 quarters.
Hillsdale Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $608K in Q2 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Hillsdale Investment Management's 13F filing for Q3 2022, filed 10 Nov 2022.